HW
REGN icon

Hamilton Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Hamilton Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,581
Closed -$7.07M – 127
2025
Q3 		$7.07M Buy
+12,581
New +$7.11M 1.48% 21
2024
Q4 		– Sell
-240
Closed -$252K – 117
2024
Q3 		$252K Hold
240
– – 0.06% 90
2024
Q2 		$252K Sell
240
-221
-48% -$214K 0.07% 80
2024
Q1 		$444K Buy
461
+193
+72% +$184K 0.14% 61
2023
Q4 		$235K Buy
+268
New +$221K 0.07% 78

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Hamilton Wealth's REGN Position: Q4 2025 in Review

Hamilton Wealth sold out of Regeneron Pharmaceuticals (REGN) in Q4 2025, closing a stake of 12,581 shares — an estimated $7.07M sold.

Hamilton Wealth first reported a position in REGN in Q4 2023 and held it in 5 quarters. The position peaked at $7.07M in Q3 2025. 1,388 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • Hamilton Wealth reported no remaining Regeneron Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Hamilton Wealth sold 12,581 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $7.07M.
  • Hamilton Wealth first reported a position in Regeneron Pharmaceuticals in Q4 2023 and held it in 5 quarters.
  • Hamilton Wealth's Regeneron Pharmaceuticals position peaked at $7.07M in Q3 2025.
  • 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on Hamilton Wealth's 13F filing for Q4 2025, filed 18 Feb 2026.